Bir sonraki

Otomatik oynatma

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 Görünümler • 07/04/23
Pay
gömmek
administrator
administrator
Aboneler
0

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma